⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mammary cancer

Every month we try and update this database with for mammary cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer SurvivorsNCT05364450
Breast Neoplasm
Breast Cancer
Breast Carcinom...
Malignant Neopl...
Cancer of Breas...
Mammary Neoplas...
Human Mammary C...
Malignant Tumor...
Mammary Cancer
Mammary Carcino...
Anxiety
Fear
Enhanced Usual ...
Acceptance Comm...
Cognitive Behav...
18 Years - 99 YearsIndiana University
Delphinus SoftVue Prospective Case Collection - ARM 1NCT03257839
Breast Neoplasm...
Routine Full-Fi...
Routine Digital...
Automated Whole...
18 Years - Delphinus Medical Technologies, Inc.
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsNCT04521686
Cholangiocarcin...
Chondrosarcoma
Glioma
Any Solid Tumor
LY3410738
Gemcitabine
Cisplatin
Durvalumab
18 Years - Eli Lilly and Company
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)NCT03157128
Non-Small Cell ...
Medullary Thyro...
Colon Cancer
Any Solid Tumor
LOXO-292
12 Years - Eli Lilly and Company
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer SurgeryNCT05408676
Mammary Cancer
PONV
electric stimul...
18 Years - 64 YearsFudan University
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer SurvivorsNCT05364450
Breast Neoplasm
Breast Cancer
Breast Carcinom...
Malignant Neopl...
Cancer of Breas...
Mammary Neoplas...
Human Mammary C...
Malignant Tumor...
Mammary Cancer
Mammary Carcino...
Anxiety
Fear
Enhanced Usual ...
Acceptance Comm...
Cognitive Behav...
18 Years - 99 YearsIndiana University
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyNCT06268665
Breast Cancer
Breast Cancer S...
Breast Cancer S...
Breast Cancer S...
Breast Cancer S...
Invasive Breast...
Ovarian Cancer
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Ovarian Cancer ...
Breast Cancer S...
Breast Cancer I...
Breast Cancer, ...
Breast Cancer, ...
Breast Cancer S...
Breast Cancer S...
Breast Cancer S...
Breast Cancer S...
Cancer, Breast
Tumors, Breast
Mammary Cancer
Mammary Carcino...
Breast Carcinom...
Breast Neoplasm
Malignant Breas...
Malignant Tumor...
Cancer of Ovary
Ovary Cancer
Ovary Neoplasm
Tart Cherry Jui...
18 Years - University of California, Davis
Delphinus SoftVue Prospective Case Collection - ARM 2NCT02977247
Breast Neoplasm...
Non-Interventio...
Automated Whole...
18 Years - Delphinus Medical Technologies, Inc.
Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)NCT04301375
Mammary Cancer
Pertuzumab and ...
Paclitaxel
TDM1
Endocrine thera...
Omission surger...
40 Years - Hospital Clinic of Barcelona
Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRINCT03022864
Chronic Pain
Mammary Cancer
18 Years - 65 YearsRenJi Hospital
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsNCT04521686
Cholangiocarcin...
Chondrosarcoma
Glioma
Any Solid Tumor
LY3410738
Gemcitabine
Cisplatin
Durvalumab
18 Years - Eli Lilly and Company
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer SurvivorsNCT05364450
Breast Neoplasm
Breast Cancer
Breast Carcinom...
Malignant Neopl...
Cancer of Breas...
Mammary Neoplas...
Human Mammary C...
Malignant Tumor...
Mammary Cancer
Mammary Carcino...
Anxiety
Fear
Enhanced Usual ...
Acceptance Comm...
Cognitive Behav...
18 Years - 99 YearsIndiana University
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544
Breast Cancer
Tumor, Breast
Breast Tumor
Malignant Neopl...
Mammary Cancer
Mammary Neoplas...
Mammary Neoplas...
Neoplasm, Breas...
HTR2 T Cells
HTR2 T Cells
18 Years - 80 YearsBaylor College of Medicine
The Effect of a Patient Decision Aids for Breast Cancer ScreeningNCT04948983
Breast Cancer
Mammary Cancer
Breast Tumor
Mammary Tumor
Decision aid (D...
Standarised inf...
50 Years - 69 YearsPontificia Universidad Catolica de Chile
Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant ReconstructionNCT06143020
Mammary Cancer
Erector Spinae ...
Postoperative P...
Erector spinae ...
18 Years - 70 YearsFudan University
Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical MastectomyNCT03204708
Mammary Cancer
catheter
iv analgesia
18 Years - 80 YearsIstanbul University
Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant ReconstructionNCT06143020
Mammary Cancer
Erector Spinae ...
Postoperative P...
Erector spinae ...
18 Years - 70 YearsFudan University
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) TumorsNCT03899792
Medullary Thyro...
Infantile Myofi...
Infantile Fibro...
Papillary Thyro...
Soft Tissue Sar...
LOXO-292
6 Months - 21 YearsEli Lilly and Company
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerNCT06251544
Breast Cancer
Tumor, Breast
Breast Tumor
Malignant Neopl...
Mammary Cancer
Mammary Neoplas...
Mammary Neoplas...
Neoplasm, Breas...
HTR2 T Cells
HTR2 T Cells
18 Years - 80 YearsBaylor College of Medicine
Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)NCT04301375
Mammary Cancer
Pertuzumab and ...
Paclitaxel
TDM1
Endocrine thera...
Omission surger...
40 Years - Hospital Clinic of Barcelona
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsNCT02611544
Breast Neoplasm...
Breast Cancer
Breast Carcinom...
Malignant Neopl...
Cancer of Breas...
Mammary Neoplas...
Human Mammary C...
Malignant Tumor...
Mammary Cancer
Mammary Carcino...
Anxiety
Fear
Neoplasm Remiss...
Spontaneous Neo...
Regression, Spo...
Remission, Spon...
Spontaneous Neo...
Acceptance and ...
Survivorship Ed...
Enhanced Usual ...
18 Years - 99 YearsIndiana University
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare SystemNCT04489992
AI (Artificial ...
Mammary Cancer
Lung Cancer
X-Rays; Lesion
COVID-19
Chest--Diseases
Abdomen Disease
Brain Disease
Fractures, Bone
18 Years - Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
The Effect of a Patient Decision Aids for Breast Cancer ScreeningNCT04948983
Breast Cancer
Mammary Cancer
Breast Tumor
Mammary Tumor
Decision aid (D...
Standarised inf...
50 Years - 69 YearsPontificia Universidad Catolica de Chile
Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer SurvivorsNCT02611544
Breast Neoplasm...
Breast Cancer
Breast Carcinom...
Malignant Neopl...
Cancer of Breas...
Mammary Neoplas...
Human Mammary C...
Malignant Tumor...
Mammary Cancer
Mammary Carcino...
Anxiety
Fear
Neoplasm Remiss...
Spontaneous Neo...
Regression, Spo...
Remission, Spon...
Spontaneous Neo...
Acceptance and ...
Survivorship Ed...
Enhanced Usual ...
18 Years - 99 YearsIndiana University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: